M&A: Page 10

  • A person looks at a computer screen with images of a person's brain.
    Image attribution tooltip
    simonkr via Getty Images
    Image attribution tooltip

    Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy

    Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.

    By • Updated Jan. 18, 2023
  • two fingers holding the Neovasc reducer heart device
    Image attribution tooltip
    Courtesy of Shockwave Medical
    Image attribution tooltip

    Shockwave to pay $100M for Neovasc, adding refractory angina treatment to device pipeline

    Neovasc already has a CE mark for the device and last year said it was targeting a 2025 approval by the FDA.

    By • Jan. 18, 2023
  • A surgeon performing an operation in a studio photo
    Image attribution tooltip
    Portra via Getty Images
    Image attribution tooltip

    ‘Mixed signals’ from medtech management suggest industry had bumpy end to 2022: analysts

    The recovery of procedure volumes was “muted and uneven” in the fourth quarter with growth throttled by hospital staffing issues and worker absenteeism.

    By • Jan. 13, 2023
  • A surgeon using the IMACTIS
    Image attribution tooltip
    Courtesy of Imactis
    Image attribution tooltip

    GE HealthCare to buy France’s IMACTIS in first acquisition as independent firm

    IMACTIS’s CT-Navigation system is used to help surgeons in minimally invasive operations and reduce procedure time. 

    By Peter Green • Jan. 11, 2023
  • Professional photo of Geoff Martha
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic CEO Martha: No more divestitures planned for 2023, but review continues

    “The portfolio review is ongoing,” CEO Geoff Martha said, even as the world's largest medtech company plans to divest dialysis, respiratory interventions and patient monitoring businesses.

    By • Jan. 9, 2023
  • A windowed building surrounded by trees with a sign "Baxter" in front
    Image attribution tooltip
    Tim Boyle via Getty Images
    Image attribution tooltip

    Baxter to spin off renal care, acute therapies units

    The company is also considering the sale of its Biopharma Solutions business.

    By • Jan. 6, 2023
  • Peter Arduini, GE Healthcare
    Image attribution tooltip
    Courtesy of GE Healthcare
    Image attribution tooltip
    Q&A

    Friday Q&A: For GE HealthCare, the future is digital, CEO Arduini says

    Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business. 

    By Peter Green • Jan. 6, 2023
  • An image of the company's bio-engineered tendon
    Image attribution tooltip
    Courtesy of Embody
    Image attribution tooltip

    Zimmer to acquire soft tissue repair firm Embody for as much as $275M

    Buying Embody’s repair system for tendons and ligaments will expand Zimmer Biomet’s share in the growing sports medicine market.

    By • Jan. 5, 2023
  • road sign shows two arrows merging
    Image attribution tooltip
    ryasick via Getty Images
    Image attribution tooltip
    Deep Dive

    A look back at medtech’s top 10 acquisitions of 2022

    While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of deals declined from 2021.

    By • Dec. 22, 2022
  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J closes acquisition of heart pump maker Abiomed

    The $16.6 billion purchase was the largest medtech transaction of 2022.

    By • Dec. 22, 2022
  • An Odin technician installing an AI endoscopy device at a hospital in Britain
    Image attribution tooltip
    Courtesy of Odin Vision
    Image attribution tooltip

    Olympus agrees to $80M takeover of artificial intelligence endoscopy startup Odin Vision

    The acquisition gives Olympus control of cloud-based AI systems to help detect and characterize cancerous and precancerous tissues during colonoscopies and gastroscopies.

    By • Dec. 21, 2022

  • Fujifilm agrees to buy Inspirata’s Dynamyx in challenge to Philips for digital pathology market

    Fujifilm struck the deal after customers told it “digitizing pathology will be the most transformative thing they do for their practice.”

    By • Dec. 21, 2022
  • Image attribution tooltip
    Medtronic
    Image attribution tooltip

    Siemens, GE Healthcare are interested in Medtronic spinoff units: Bloomberg

    Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.

    By • Dec. 15, 2022
  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes
    Image attribution tooltip

    Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market

    The deal will give Tandem control of Sigi, a reusable, rechargeable patch pump that is designed to be smaller and lighter than existing devices.

    By • Dec. 14, 2022
  • A technician illustrating the use of the SD Biosensor technology
    Image attribution tooltip
    Courtesy of SD Biosensor
    Image attribution tooltip

    SD Biosensor postpones closing of $1.53B Meridian acquisition to complete financing

    SD Biosensor, a company known in the West for its work with Roche, struck the deal to buy Meridian in July to expand into the U.S. in vitro diagnostic market.

    By • Dec. 14, 2022
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific pays $523M for control of Chinese device maker Acotec

    The acquisition will give Boston greater access to the Chinese market, which the U.S. firm expects will account for 25% of the global medtech demand by 2030.

    By Peter Green • Dec. 12, 2022
  • CEO Peter Arduini (L) and CFO Helmut Zodl (R) of GE Healthcare after a presentation to investors at Times Square in New York City.
    Image attribution tooltip
    Peter S Green/MedTech Dive
    Image attribution tooltip
    Q&A

    Friday Q&A: GE Healthcare’s Arduini, Zodl talk about spinoff, M&A, margins, Jack Welch

    The CEO and CFO of the company spoke with MedTech Dive just weeks before the healthcare business formally separates from General Electric.

    By Peter Green • Dec. 9, 2022
  • Image attribution tooltip
    Carl Court via Getty Images
    Image attribution tooltip

    Cochlear’s $120M purchase of hearing-implant maker stirs European scrutiny

    The European Commission said the merger “threatens to significantly affect competition in the market for cochlear implants and bone conduction solutions.”

    By • Dec. 9, 2022
  • People using an indego exoskeleton
    Image attribution tooltip
    Courtesy of Indego
    Image attribution tooltip

    Ekso Bionics buys Indego lower limb exoskeleton business from Parker Hannifin for $10M

    Indego and planned robotic assisted orthotic and prosthetic devices will slot into a portfolio of wearable robotics designed to tackle mobility loss. 

    By • Dec. 7, 2022
  • Team of surgeons operating on patient in hospital - stock photo Four doctors in hospital operating room with patient lying on operating table. Surgical lights shining on medical team performing operat
    Image attribution tooltip
    Johnny Greig via Getty Images
    Image attribution tooltip

    The 10 biggest medtech stories of 2022

    MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

    By MedTech Dive staff • Dec. 3, 2022
  • A surgeon holds a piece of surgical mesh for hernia and abdominal wall surgery.
    Image attribution tooltip
    Courtesy of Integra
    Image attribution tooltip

    Integra to buy Surgical Innovation Associates for $50M in bid to lead growing breast reconstruction niche

    Human-derived surgical matrices dominate the market but Interga thinks synthetic and xenograft devices will gain ground.

    By • Dec. 2, 2022
  • A GE Healthcare C-arm imaging device
    Image attribution tooltip
    Courtesy of GE Healthcare
    Image attribution tooltip

    GE’s board finalizes healthcare spinoff

    The new company, GE Healthcare, will be the sixth largest global medtech company when it starts trading on Nasdaq on Jan. 4.

    By • Dec. 1, 2022
  • Image attribution tooltip
    Boston Scientific
    Image attribution tooltip

    Boston Scientific to buy Apollo Endosurgery for $615M as entry into endobariatric market

    The acquisition values Apollo shares at two-thirds above their closing price Monday, and may herald a new trend in medtech M&A, says an analyst.

    By • Nov. 29, 2022
  • A headshot of ResMed CEO Mick Farrell.
    Image attribution tooltip
    Permission granted by ResMed
    Image attribution tooltip

    ResMed closes $1B Medifox buyout to expand software business into Europe

    The takeover gives ResMed control of a 700-person operation that offers similar solutions to its existing U.S. brands MatrixCare and Brightree.

    By • Nov. 23, 2022
  • Brittany Baretto is a leading FemTech venture capitalist
    Image attribution tooltip
    Permission granted by Brittany Barreto
    Image attribution tooltip
    Q&A

    Friday Q&A: FemTech Focus’s Barreto discusses women’s health innovations, funding challenges

    The executive director of the nonprofit group explains why women's health is finally getting attention and what the FemTech revolution is all about.

    By • Nov. 4, 2022